- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Sectors
Lodo likes the sound of acquisition
Zymergen has purchased Lodo Therapeutics, which is advancing Rockefeller research, for an undisclosed sum five years after the company raised its only funding round.
May 28, 2021Lyell Immunopharma lines up $150m IPO
The GlaxoSmithKline and Celgene-backed immunotherapy developer has revealed its intention to float on the Nasdaq Global Market.
May 28, 2021Effector exercises reverse merger
The Pfizer, GlaxoSmithKline, Novartis, AbbVie and Astellas-backed oncology therapy developer is set to go public through a reverse takeover.
May 27, 2021SoftBank lands on Perch for $775m round
SoftBank Vision Fund 2 led the e-commerce holding company's latest round, reportedly the largest series A ever closed by a US-based company.
May 27, 2021Flywire ties up $251m initial public offering
The payment software provide's shared popped on their first day after an IPO that followed two Goldman Sachs-backed funding rounds.
May 27, 2021Ivi activates $250m series D
VTB has led the Prof-Media-backed video streaming service’s series D round, which reportedly brought its overall financing to $438m.
May 27, 2021Invaio Sciences infused with series C funding
Alexandria Venture Investments has participated in an $88.9m round which has pushed the biotech developer's total funding past $142m.
May 27, 2021Novo escorts Esco to $200m series A
The pharmaceutical firm co-led a series A equity and crossover financing round for the life sciences tool provider that will fund Chinese expansion.
May 27, 2021NiKang nicks $200m in series C round
Lilly Asia Ventures has returned to back the immuno-oncology therapy developer’s latest round, eight months after participating in the company’s series B.
May 27, 2021AMTD digital unit to be spun off in US IPO
AMTD Group is looking to spin off its digital financial services arm, which counts Maoyan Entertainment as an investor, through an initial public offering in the United States.
May 27, 2021Akili scores $160m in series D funding
Shionogi has joined subsidiaries of Merck Group and Amgen in the equity portion of a series D round for the digital therapeutics developer.
May 27, 2021Pulmocide pulls in $92m
Asahi Kasei, GlaxoSmithKline and Johnson & Johnson helped the respiratory disease drug developer boost its overall funding to $150m.
May 27, 2021Featured Content
GCVI Summit 2026 RewindRewatch the sessions, recap the learningsGCVI Summit 2026 Rewind
Rewatch the sessions, recap the learnings
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
GCV’s Rising Stars and Emerging Leaders 2026The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.GCV’s Rising Stars and Emerging Leaders 2026
The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
